Influence of interleukin-4 on the phenotype and function of bone marrow-derived murine dendritic cells generated under serum-free conditions

被引:31
作者
Wells, JW [1 ]
Darling, D [1 ]
Farzaneh, F [1 ]
Galea-Lauri, J [1 ]
机构
[1] Kings Coll London, GKT Sch Med, Rayne Inst, Dept Haematol & Mol Med, London SE5 9NU, England
关键词
D O I
10.1111/j.1365-3083.2005.01556.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Murine bone marrow-derived dendritic cells (DC) can be generated by culture in the presence of granulocyte/macrophage colony-stimulating factor (GM-CSF) alone or GM-CSF in conjunction with interleukin-4 (IL-4). However, these two culture methods result in the production of heterogeneous DC populations with distinct phenotypic and stimulatory properties. In this study, we investigated the properties of DC generated under serum-free conditions in the presence or absence of IL-4 and compared their yield and phenotype to that of DC generated in the presence of fetal calf serum (FCS) ( IL-4). We did not observe a significant difference in the total cell yield between these four culture conditions, although the proportion of CD11c(+) DC in cultures that received FCS was higher than that of their counterparts generated under serum-free conditions. Also, the four culture conditions generated CD11c(+) DC with comparable levels of major histocompatibility complex (MHC) class II, CD40, CD80 and CD86 expression, with the exception of cells cultured under serum-free conditions in the absence of IL-4, which displayed suboptimal levels of these markers. Moreover, we compared the functional and stimulatory properties of DC generated under serum-free conditions in the presence or absence of IL-4. DC cultured in the presence of IL-4 were stronger stimulators of allogeneic splenocytes in a primary mixed lymphocyte reaction (MLR) and of naive antigen-specific OT-II transgenic T cells when pulsed with the class II ovalbumin (OVA)(323-339) peptide or whole OVA protein than DC cultured in the absence of IL-4. However, both DC populations displayed a similar capacity to take up fluorescein isothiocyanate (FITC)-albumin by macropinocytosis and FITC-Dextran by the mannose receptor and to secrete IL-12 in response to stimulation with lipopolysaccharide (LPS) or an agonistic anti-CD40 monoclonal antibody. Therefore, we conclude that although both DC culture methods result in the production of DC with similar functional abilities, under serum-free conditions, DC cultured in GM-CSF and IL-4 show an increased stimulatory potential over DC cultured in GM-CSF alone. This is an important consideration in the design of experiments where DC are being exploited as immunotherapeutic vaccines.
引用
收藏
页码:251 / 259
页数:9
相关论文
共 36 条
  • [1] Dendritic cells and the control of immunity
    Banchereau, J
    Steinman, RM
    [J]. NATURE, 1998, 392 (6673) : 245 - 252
  • [2] Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements
    Barnden, MJ
    Allison, J
    Heath, WR
    Carbone, FR
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 1998, 76 (01) : 34 - 40
  • [3] Buchele S, 1997, ADV EXP MED BIOL, V417, P233
  • [4] Origin, maturation and antigen presenting function of dendritic cells
    Cella, M
    Sallusto, F
    Lanzavecchia, A
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (01) : 10 - 16
  • [5] Priming to mycobacterial antigen in vivo using antigen-pulsed antigen presenting cells generated in vitro is influenced by the dose and presence of IL-4 in APC cultures
    Dillon, SM
    Hart, DNJ
    Abernethy, N
    Watson, JD
    Baird, MA
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1997, 46 (01) : 1 - 9
  • [6] Production of IL-12 by human monocyte-derived dendritic cells is optimal when the stimulus is given at the onset of maturation, and is further enhanced by IL-4
    Ebner, S
    Ratzinger, G
    Krösbacher, B
    Schmuth, M
    Weiss, A
    Reider, D
    Kroczek, RA
    Herold, M
    Heufler, C
    Fritsch, P
    Romani, N
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (01) : 633 - 641
  • [7] Eggert AO, 2002, EUR J IMMUNOL, V32, P122, DOI 10.1002/1521-4141(200201)32:1<122::AID-IMMU122>3.0.CO
  • [8] 2-C
  • [9] Phenotypic and functional characteristics of BM-derived DC from NOD and non-diabetes-prone strains
    Feili-Hariri, M
    Morel, PA
    [J]. CLINICAL IMMUNOLOGY, 2001, 98 (01) : 133 - 142
  • [10] Immunotherapy of NOD mice with bone marrow-derived dendritic cells
    Feili-Hariri, M
    Dong, X
    Alber, SM
    Watkins, SC
    Salter, RD
    Morel, PA
    [J]. DIABETES, 1999, 48 (12) : 2300 - 2308